Successful olaparib desensitization using a novel one-day protocol

Olaparib is a revolutionary treatment for patients with ovarian and breast cancer. Currently, there is no established 1-day drug desensitization protocol for patients with olaparib type-1 hypersensitivity reac...

Source: Allergy, Asthma and Clinical Immunology - November 11, 2020 Category: Allergy & Immunology Authors: Rongbo Zhu, Stephen Welch and Hannah Roberts Tags: Case report Source Type: research